A combination approach
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
Last year, a team of researchers at the Case Western Reserve University School of Medicine studied 1.6 million patients with type 2 diabetes and found that those on GLP-1 drugs had significant risk reduction of ten cancers: esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancer, as well as meningioma and multiple myeloma
Molecular Architecture Designing Balanced Activity Across Three Receptors Designing a balanced triple-receptor agonist is substantially more constrained than designing a single-receptor or dual-receptor compound
Some telehealth companies like Ro and Hims hire third-party companies to test the compounded medications for quality and purity, but not all of them do